Showing results (1021-1030 of 1,182) with videos related to
Sort By:
Pageof 119
Applied Health Economics and Health Policy|November 7, 2025
Cost-Utility Analysis of TAVI Versus Surgery in Low-Risk Patients with Severe Aortic Stenosis in the UKNick Curzen, Pascal Candolfi, Philip MacCarthy, et al.Applied Health Economics and Health Policy|September 23, 2025
Burden of Disease in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Scoping ReviewPatricia Vester, Stefanos Boudouroglou-Walter, Jonas Schreyögg, et al.Applied Health Economics and Health Policy|March 28, 2025
Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative AssessmentLudovico Cavallaro, Vittoria Ardito, Michael Drummond, et al.Applied Health Economics and Health Policy|July 25, 2014
E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta: a NICE medical technology guidanceMuralikrishnan Radhakrishnan, Janet Peacock, Tiago Rua, et al.Applied Health Economics and Health Policy|July 26, 2014
What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancerM Barbieri, H L A Weatherly, R Ara, et al.Applied Health Economics and Health Policy|July 26, 2014
EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing: a NICE medical technology guidanceAilish Higgins, Matthew Glover, Yaling Yang, et al.Applied Health Economics and Health Policy|August 4, 2014
Cost effectiveness of renal denervation therapy for the treatment of resistant hypertension in the UKDaniel Gladwell, Thea Henry, Mark Cook, et al.Applied Health Economics and Health Policy|December 7, 2013
Economic burden and disparities in healthcare resource use among adult patients with cardiac arrhythmiaDerek H Tang, Adrienne M Gilligan, Klaus RomeroApplied Health Economics and Health Policy|March 16, 2013
Measuring the loss of consumer choice in mandatory health programmes using discrete choice experimentsBonny Parkinson, Stephen Goodall, Richard NormanApplied Health Economics and Health Policy|May 3, 2013
Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosisAnnie Hawton, James Shearer, Elizabeth Goodwin, et al.Pageof 119